Mdachi, R. E.; Kagira, J. M.; Thuita, J. K.; Ngotho, J. M.; Murilla, G. A.; Ndung’u, J. M.
(2017-02-09)
10 to 30 days to facilitate treatment with parenterally administered medicines. The efficacy of a novel
orally administered prodrug, 2,5-bis(4-amidinophenyl)-furan-bis-O-methlylamidoxime (pafuramidine,
DB289), was tested ...